Haematological cancer: Indolent lymphoma--why not to sprint at the start of a marathon
Nat Rev Clin Oncol
.
2013 May;10(5):251-2.
doi: 10.1038/nrclinonc.2013.53.
Epub 2013 Apr 16.
Authors
Stephane Doucet
,
Leo I Gordon
PMID:
23591322
DOI:
10.1038/nrclinonc.2013.53
No abstract available
Publication types
News
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Lymphoma, Mantle-Cell / drug therapy*